1
|
Kosztin A, Merkel E, Merkely B. Association of left atrial enlargement and increased left ventricular wall thickness with arrhythmia recurrence after cryoballoon ablation for atrial fibrillation. Kardiol Pol 2022; 80:1070-1071. [PMID: 36477905 DOI: 10.33963/kp.a2022.0277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2022] [Accepted: 12/08/2022] [Indexed: 12/13/2022]
Affiliation(s)
- Annamaria Kosztin
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
| | - Eperke Merkel
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Bela Merkely
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| |
Collapse
|
2
|
Kuthi L, Schwertner W, Veres B, Merkel E, Behon A, Masszi R, Kovacs A, Osztheimer I, Molnar L, Zima E, Geller L, Kosztin A, Merkely B. The impact of frailty index on long-term outcome in CRT patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Frailty is a complex clinical syndrome associated with ageing and comorbidities resulting from multiple organ impairment by losing homeostatic reserves and increased vulnerability to physiological decompensation. Frailty can be measured by quantifying the “vulnerability status” by the range of comorbidities.
Purpose
We assessed the long-term all-cause mortality based on Frailty Index (FI) among patients who underwent Cardiac Resynchronization Therapy (CRT) implantation.
Methods
We calculated patients' FI individually using 30 clinical parameters from our retrospective single centre large-scale registry. The applied clinical features incorporated patients' medical history, anthropometric-, laboratory and echocardiographic parameters. Based on previous studies, patients with FI ≤0.210 were classified as non-frail, and patients above that value were considered frail. Frail patients were divided into two different subgroups (F1; F2) by a FI increment of 0.100 based on the Rockwood method. Primary endpoint was all-cause mortality, log-rank and Cox multivariate analysis were performed.
Results
Among 1010 included patients, 58 (6%) were considered as Non-frail, while 245 (24%) and 707 (70%) participants were categorized to F1- and F2 groups. Patients in F2 group were older [non-frail 62 years (IQR 57–68) vs. F1 66 years (IQR 57–73) vs. F2 70 years (IQR 63–76); p<0.001], had worse laboratory parameters as higher creatinine, uric acid, lower sodium or hemoglobin levels (p<0.001) and more comorbidities than patients of Non-frail or F1 groups. During the median follow-up time of 4.4 (2.3–6.9) years, 17 (29%) patients in the Non-frail group, 103 (42%) in Frail group 1 and 479 (68%) in the Frail group 2 reached the primary endpoint. Non-frail patients showed the best outcome, and patients in the Frail group 1 demonstrated a 46% (HR 0.46, 95% CI 0.39–0.55; p<0.001) lower all-cause mortality risk compared to Frail group 2. In the total cohort, mortality predictors were also assessed, NYHA functional class, serum sodium, creatinine and TAPSE were identified as independent predictors of all-cause mortality.
Conclusion
By calculating individual frailty index among CRT patients, distinct groups could be identified, of which mortality differed significantly. Those with the highest Frailty index demonstrated the worse outcome compared to lower index or non-frail patients. Frailty index can help selecting the most vulnerable patients, requiring a strict follow-up.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- L Kuthi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - W Schwertner
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - R Masszi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
3
|
Schwertner WR, Tokodi M, Behon A, Veres B, Merkel E, Kuthi L, Masszi R, Kovacs A, Zima E, Geller L, Osztheimer I, Kosztin A, Merkely B. Pacemaker upgrade to Cardiac Resynchronization Therapy-defibrillator or Cardiac Resynchronization Therapy-pacemaker without prior ventricular arrhythmias. Europace 2022. [DOI: 10.1093/europace/euac053.486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This work was supported by the ÚNKP-21-3-II-SE-47, ÚNKP-20-3-I-SE-43 New National Excellence Program if the Ministry for Innovation and Technology in Hungary. Project no. NVKP_16-1–2016-0017 (’National Heart Program’) has been implemented with the support provided by the National Research, Development and Innovation Fund of Hungary, funded under the NVKP_16 funding scheme. The research was financed by the Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University. This work was also supported by the Semmelweis 250+ Excellence PhD Scholarship (EFOP-3.6.3-VEKOP-16-2017-00009).
Background
Cardiac Resynchronization Therapy (CRT) can reverse the harmful effects of right ventricular pacing (RVP). Data are scarce on comparing long-term survival among patients who undergone CRT-defibrillator (CRT-D) or CRT-pacemaker (CRT-P) upgrade from pacemakers (PM) without prior ventricular arrhythmias (VAs).
Purpose
We compared the differences in long-term all-cause mortality among PM patients receiving CRT-D or CRT-P upgrade.
Methods
Patients with conventional PMs developing heart failure despite optimal medical treatment and a high rate of RVP with no prior VAs were included. Altogether 326 patients were investigated, 117 (36%) upgraded to CRT-D, 209 (64%) to CRT-P in our retrospective registry. The primary endpoint was all-cause mortality. Subgroup analyses were performed by comorbidities and CRT device types. Using topological data analysis, we identified risk groups based on the primary endpoint.
Results
During the median follow-up time of 3.6 years, 33 (28%) CRT-D and 145 (69%) of CRT-P upgrade patients reached the primary endpoint. The CRT-D upgrade group showed a lower risk of all-cause mortality in the total cohort (HR: 0.55; 95% CI: 0.38-0.81; p=0.002) and by ischaemic aetiology (HR: 0.47; 95% CI: 0.29-0.76; p=0.002) compared to CRT-P. After adjustment, CRT-D, male gender and loop diuretics proved as independent predictors of all-cause mortality. Patients upgraded with CRT-D demonstrated favourable survival in the high-risk group over CRT-P.
Conclusions
Patients had survival benefit after CRT-D upgrade, compared to CRT-P, in the high-risk group and with ischaemic heart failre aetiology. However, no difference could be observed between the two groups among low- and intermediate-risk patients.
Collapse
Affiliation(s)
- W R Schwertner
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Tokodi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Kuthi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - R Masszi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
4
|
Masszi R, Merkel E, Schwertner W, Veres B, Behon A, Pinter A, Osztheimer I, Zima E, Geller L, Becker D, Kosztin A, Merkely B. The effect of implantable cardioverter defibrillator in patients with cardiac resynchronizational therapy and diabetes mellitus. Europace 2022. [DOI: 10.1093/europace/euac053.494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): (NKFIA; NVKP_16-1-2016-0017 National Heart Program).
Background
Heart failure (HF) and diabetes mellitus (DM) are common causes of death on their own, but the coexistance of these two diseases are especially fatal. 1 In DM, sudden cardiac death (SCD) is more common than in non-DM patients, however in many cases, implantable cardioverter defibrillator (ICD) could not prevent SCD. 2
Purpose
Our aim is to decide which device warrant higher life expectancy, cardiac resynchronizational therapy with or without defibrillator.
Methods
We examined retrospectively 2525 CRT implanted patients, with a mean follow-up time of 4.6 years. Implantaions were based on the current guidelines. The primary endpoint was all-cause mortality, while our composite end-point were all-cause mortality and heart failure hospitalization.
Results
In our population, 928 people (36%) had diabetes. We did not find statistical differences between age (68 vs. 68 years; p<0.099), gender (26% women, 23% women; p<0.08) LVEF (28% vs. 29% p<0.1425), incidence of atrial fibrillation (37% vs. 38%; p<0.76), implantation of an ICD (53% vs. 54%; p<0.847), NT-proBNP median levels (2939 pg/ml vs. 2778 pg/ml; p<0.35), and NYHA I (0,5% vs. 0,5%; p<0.898), and NYHA IV stadium (11% vs. 11%; p<0,82). However DM patients had higher BMI (28 kg/m2 vs. 26 kg/m2; p<0.001), lower eGFR levels (57 ml/min/1,73m2 vs. 60 ml/min/1,73m2; p<0.011) higher prevalence of hypertonia (82% vs. 66%; p<0.001), NYHA III stadium (39% vs. 33%; p<0,0008), ischemic etiology (56% vs. 44%; p<0.001), previous acute myocardial infartion (42,9% vs. 36%; p<0.001), a percutan coronaria intervention (35% vs. 25%; p<0.001) compared to non-DM patients. Those patients with DM showed a 25% higher risk of all-cause mortality (HR 1.25; 95% CI 1.12-1.40; p‹0.01) then non-DM patientes, also observable after adjusting for relevant clinical covariates such as age, gender, atrial fibrillation and the addition of an ICD (HR 1.17; 95% CI 1.06-1.31; p‹0.01).
Conclusions
Adding an ICD for CRT patients with diabetes reduces the risk of all-cause mortality significantly by 32% (HR 0,68; CI 0,56-0,82; p‹0.001) during the first six years but diminished on longer follow-up time (HR 0,95; CI 0,80-1,12; p=0,54).
Collapse
Affiliation(s)
- R Masszi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - W Schwertner
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Pinter
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
5
|
Șulea CM, Lakatos B, Kovács A, Benke K, Suhai FI, Csulak E, Merkel E, Nagy B, Hartyánszky I, Merkely B, Szabolcs Z, Pólos M. Blood-filled cyst of the tricuspid valve: Multiple cardiac disorders, one surgical case. J Card Surg 2021; 37:245-248. [PMID: 34713934 DOI: 10.1111/jocs.16108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Accepted: 10/17/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND Intracardiac blood cysts are an exceedingly rare occurrence in adulthood. Detailed imaging modalities aid in the diagnosis of such incidental lesions and procedure planning. METHODS We report the case of a 51-year-old male accusing dyspnea on exertion as a sole symptom which led to the discovery of multiple cardiac anomalies, namely, severe aortic valve insufficiency on a bicuspid aortic valve, ascending aortic aneurysm, a cystic mass on the tricuspid valve, patent foramen ovale, and an occluded right coronary artery. RESULTS The disorders were managed in a single surgical intervention, the resected mass being confirmed as a blood cyst. CONCLUSIONS Our case presents a unique association of cardiac disorders, including a highly uncommon intracardiac blood-filled cyst, and underlines the importance of multimodality imaging and interdisciplinary approach in the successful management of such complex cases.
Collapse
Affiliation(s)
- Cristina M Șulea
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Bálint Lakatos
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Attila Kovács
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Kálmán Benke
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Ferenc I Suhai
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Emese Csulak
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Eperke Merkel
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Beáta Nagy
- First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
| | | | - Béla Merkely
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Zoltán Szabolcs
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Miklós Pólos
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| |
Collapse
|
6
|
Schwertner WR, Kosztin A, Behon A, Merkel E, Kuthi L, Veres B, Tokodi M, Kovacs A, Osztheimer I, Kiraly Á, Geller L, Merkely B. Long-term mortality benefit of CRT-D vs. CRT-P upgrade procedures from conventional devices without prior ventricular arrhythmias. Europace 2021. [DOI: 10.1093/europace/euab116.461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This work was supported by the ÚNKP-20-3-I New National Excellence Program if the Ministry for Innovation and Technology in Hungary, the National Research, Development, and Innovation Office of Hungary (NKFIA; NVKP_16-1-2016-0017 National Heart Program), and the Higher Education Institutional Excellence Program of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development thematic program of the Semmelweis University. This work was also supported by the Artificial Intelligence Research Filed Excellence Program of the National Research, Development and Innovation Office of the Ministry of Innovation and Technology in Hungary (TKP/ITM/NKFIH). The research was also financed by the Thematic Excellence Program (Tématerületi Kiválósági Program, 2020-4.1.1-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Bioimaging thematic program of the Semmelweis University.
Background
Cardiac Resynchronization Therapy (CRT) upgrade can reverse pacing-induced cardiomyopathy (PiCMP) and related major ventricular arrhythmias (MVA). However, there is a lack of data comparing mortality benefit of adding an ICD to CRT during upgrade procedures in those without prior malignant ventricular arrhythmias (VAs).
Purpose
We aimed to compare the all-cause mortality, echocardiographic response, MVA occurrence and the rate of complications of patients with prior pacemakers (PM) upgraded to CRT-P or CRT-D devices.
Methods
Between 2000-2018 patients who underwent a successful CRT upgrade procedure from conventional pacemaker without a prior MVAs were collected. From 270 patients 83 (30.7%) upgraded to CRT-D, 187 (69.3%) to CRT-P device. The primary endpoint was all-cause mortality, secondary endpoints were echocardiographic response defined as left ventricular ejection fraction (LVEF) increase ≥5%, the occurrence of subsequent MVAs and the rate of periprocedural complications.
Results
CRT-D upgrade patients were more likely to be males, have a favourable renal function and lower LVEF compared to CRT-P group. During the median follow-up time of 3.7 years, 25 (30%) CRT-D and 131 (70%) CRT-P upgrade patients reached the primary endpoint. By univariate analysis, CRT-D upgrade patients showed 45% (HR 0.55; 95%CI 0.38-0.78; p < 0.01) lower all-cause mortality risk than CRT-P group. By multivariate analysis CRT-D (HR 0.39; 95%CI 0.23-0.66; p < 0.01), male sex (HR 1.60; 95%CI 1.03-2.47; p = 0.04), LVEF (HR 0.97; 95%CI 0.94-0.99; p < 0.01) have confirmed as independent predictors of all-cause mortality. Assessing secondary endpoints, LVEF response (66% vs 63%; p = 0.72), MVA occurrence (3.4% vs 0.8%; p < 0.01) and the rate of periprocedural complications were comparable in the two groups (14.8% vs 7%; p = 0.87), despite the higher number of lead explantations during CRT-D procedures than CRT-P upgrade (13% vs 1%; p < 0.001).
Conclusions
Adding an ICD during CRT upgrade procedures showed 45% lower all-cause mortality risk than CRT-P alone in patients with a pacemaker and no previous ventricular arrhythmias. This beneficial effect was independent of the echocardiographic response, safety or subsequent ventricular arrhythmias. Abstract Figure.
Collapse
Affiliation(s)
- WR Schwertner
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Kuthi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Tokodi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Á Kiraly
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
7
|
Pólos M, Domokos D, Şulea CM, Benke K, Csikós G, Nagy A, Skoda R, Szabó A, Merkel E, Hartyánszky I, Szabolcs Z, Merkely B, Becker D. Needle in the heart: a rare case of cardiac tamponade caused by a migrated foreign body and mimicking ST segment elevation myocardial infarction. BMC Cardiovasc Disord 2021; 21:143. [PMID: 33730997 PMCID: PMC7972190 DOI: 10.1186/s12872-021-01950-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Accepted: 03/09/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Pericardial tamponade is a serious condition which may eventually lead to severe haemodynamic disturbances and cardiac arrest. It is most often caused by the accumulation of fluid inside the pericardium, as a result of different aetiological factors such as pericarditis, neoplastic diseases, lymphatic dysfunctions, or idiopathic pericardial disease. Pericardial tamponade can develop after cardiac surgical procedures or as a complication of myocardial infarction. Collection of blood inside the pericardial sack can be the result of pericardial or cardiac trauma. It is exceedingly rare for the injury to be caused by a migrating foreign body. Although a typical picture of pericardial tamponade has been previously described, the disorder may clinically resemble an acute myocardial infarction. CASE PRESENTATION We report the case of a 58-year-old female patient complaining of new onset thoracic pain and shortness of breath. Electrocardiographic examination results were suggestive of an acute inferior myocardial infarction. However, echocardiography revealed significant pericardial tamponade. The cause was found to be a needle which remained inside the pelvis following a previous cesarean delivery, which the patient had undergone 18 years prior. In emergency setting, the needle was removed and the pericardial tamponade was resolved. Due to the prompt and efficient management, the patient had an uneventful postoperative recovery and presented no recurrence at the follow-up examinations. CONCLUSIONS The migration of foreign bodies through tissues is exceedingly rare. If present, it may cause life-threatening complications. Since the aetiology of pericardial tamponade is vast, a thorough assessment is highly important. Therefore, echocardiography is the imaging modality of choice. We wish to highlight the possibility of migrating foreign bodies as probable cause for pericardial tamponade, as well as the importance of echocardiographic methods in the fast-track evaluation of such critical conditions.
Collapse
Affiliation(s)
- Miklós Pólos
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary.
| | - Dominika Domokos
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - Cristina-Maria Şulea
- George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania
| | - Kálmán Benke
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - Gergely Csikós
- Department of Anesthesiology and Intensive Care, Semmelweis University, Budapest, Hungary
| | - Andrea Nagy
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - Réka Skoda
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - András Szabó
- Department of Anesthesiology and Intensive Care, Semmelweis University, Budapest, Hungary
| | - Eperke Merkel
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - István Hartyánszky
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - Zoltán Szabolcs
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - Béla Merkely
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| | - Dávid Becker
- Heart and Vascular Center, Semmelweis University, Varosmajor Str. 68, 1122, Budapest, Hungary
| |
Collapse
|
8
|
Kosztin A, Schwertner WR, Behon A, Merkel E, Zima E, Geller L, Becker D, Merkely B. P577Effect of adding an implantable cardioverter defibrillator on long-term survival in non-ischemic CRT patients stratified by Goldenberg risk score. Europace 2020. [DOI: 10.1093/europace/euaa162.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
There are limited and incomprehensive long-term data on the effects of adding an implantable cardioverter defibrillator (ICD) to cardiac resynchronization therapy (CRT) in patients with non-ischemic heart failure.
Purpose
We compared the long-term all-cause mortality and relative risk reduction in mortality of non-ischemic patients after CRT-P vs. CRT-D implantation stratified by their Goldenberg risk score.
Methods
In our retrospective registry, data of 1196 non-ischemic patients who underwent CRT implantation between 2000 to 2018 were collected. Goldenberg sudden cardiac risk score was calculated by the presence of atrial fibrillation, NYHA class > 2, age > 70 years, blood urea nitrogen > 26mg/dl and QRS width.
Results
In our registry from 1196 CRT implanted patients with non-ischemic heart failure, 716 patients had all the required data to calculate the Goldenberg score. From this cohort 379 (53%) had CRT-P and 337 (47%) CRT-D implantation. The mean value of the Goldenberg score was 2.7 in the total cohort, while a significantly higher score was found in the CRT-P group (CRT-P 2.9 ± 1.1 vs. CRT-D 2.5 ± 1.1 p < 0.001). During the median follow-up time of 4.9 years, 345 (48%) patients reached the primary endpoint, 220 patients (64%) with CRT-P and 125 patients (36%) with CRT-D. After comparing patients by low (≤3) and high (>3) Goldenberg score, we found that CRT-D patients with lower risk score showed mortality benefit compared to CRT-P (HR 0.69; 95%, CI 0.53-0.89; p = 0.001). In the contrary there was no apparent mortality benefit in CRT-D patients compared to CRT-P when high Goldenberg score subgroup was analyzed (HR 0.99; 95%, CI 0.67-1.45; p = 0.95).
Conclusions
In non-ischemic heart failure patients, Goldenberg sudden cardiac risk score can be also applied. In CRT-D patients those with less co-morbidities and lower (≤3) Goldenberg risk score showed mortality benefit compared to CRT-P patients, while among patients with higher score (>3) adding an ICD had no additional effect on all-cause mortality.
Collapse
Affiliation(s)
- A Kosztin
- Semmelweis University, Heart Center, Budapest, Hungary
| | | | - A Behon
- Semmelweis University, Heart Center, Budapest, Hungary
| | - E Merkel
- Semmelweis University, Heart Center, Budapest, Hungary
| | - E Zima
- Semmelweis University, Heart Center, Budapest, Hungary
| | - L Geller
- Semmelweis University, Heart Center, Budapest, Hungary
| | - D Becker
- Semmelweis University, Heart Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Heart Center, Budapest, Hungary
| |
Collapse
|
9
|
Kosztin A, Boros AM, Merkel E, Schwertner WR, Behon A, Merkely B. Improved life expectancy in patients after dual-chamber pacemaker implantation. Kardiol Pol 2019; 77:659-660. [DOI: 10.33963/kp.14938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
10
|
Thalmann R, Merkel E, Akra B, Bombien R, Fano C, Dauner M, Kozlik-Feldmann R, Sodian R, Neagoie A, Aleksieva G, Neuss M, Reichart B, Schmitz C. Development of a large animal model for hybrid pulmonary valve implantation. Thorac Cardiovasc Surg 2011. [DOI: 10.1055/s-0030-1269152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Lang N, Mever A, Merkel E, Thalmann R, Lehner A, Freudenthal F, Vasilyev N, del Nido P, Netz H, Kozlik-Feldmann R. Evaluation of a self-centering patch system for closure of muscular ventricular septal defects in a pig model. Thorac Cardiovasc Surg 2010. [DOI: 10.1055/s-0029-1246778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
12
|
Lang N, Sigler M, Merkel E, Fuchs F, Schumann D, Klemm D, Kramer F, Meyer A, Thalmann R, Lehner A, Freudenthal F, Netz H, Kozlik-Feldmann R. Evaluation of bacterial cellulose as a new patch material for closure of muscular ventricular septal defects. Thorac Cardiovasc Surg 2010. [DOI: 10.1055/s-0029-1246848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
13
|
Dress K, Rölle T, Wenzel A, Bösherz G, Frommknecht N, Merkel E, Sauer W. Sub Room Temperature Differential Vapor Pressure Osmometry: A Method for the Determination of the Aggregation Number of α-Heterosubstituted Organolithium Compounds and Lithium Amides in Solution. Z PHYS CHEM 2009. [DOI: 10.1524/zpch.2001.215.1.077] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Abstract
The aggregation number of α-Selenium- and α-Sulfur-substituted organolithium compounds, lithium amides, and transition metal complexes in solution has been determined by sub room temperature differential vapor pressure osmometry. This novel method allows measurements of oxygen, moisture, and temperature sensitive compounds. The aggregation number of these compounds can be determined in THF solutions at 0°C and in diethyl ether solutions at -35°C.
Collapse
|
14
|
|
15
|
Martin D, Merkel E, Tucker KK, McManaman JL, Albert D, Relton J, Russell DA. Cachectic effect of ciliary neurotrophic factor on innervated skeletal muscle. Am J Physiol 1996; 271:R1422-8. [PMID: 8945982 DOI: 10.1152/ajpregu.1996.271.5.r1422] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Recombinant human ciliary neurotrophic factor (rh-CNTF) was reported to attenuate skeletal muscle wasting in rats after unilateral transection of the sciatic nerve (M. E. Helgren, S. P. Squinto, H. L. Davis, D. J. Parry, T. G. Bolton, C. S. Heck, Y. Zhu, G. D. Yancopoulos, R. M. Lindsay, and P. S. DiStefano. Cell 76: 493-504, 1994). Under the experimental conditions reported herein, the absolute masses of the denervated gastrocnemius and soleus muscles were not increased in mature or immature rats of either sex by treatment with rhCNTF. At the highest doses of rhCNTF (1 and 0.1 mg/kg), increases in the ratio of the masses of the denervated to the contralateral innervated gastrocnemius and soleus muscles could be attributed entirely to a muscle-wasting effect on the contralateral innervated muscle rather than any muscle-sparing effect on the denervated muscle. The muscle-wasting effects of rhCNTF were associated with reductions in body weight gain and reduced food intake. Pair-fed rats lost less body weight and skeletal muscle mass than rhCNTF-injected freely fed rats but experienced significantly greater loss of visceral mass. Male rats displayed greater loss of body weight and skeletal muscle mass than female rats. Recombinant inhibitors of the cachectic cytokines, tumor necrosis factor and interleukin-1, did not significantly alter the wasting effects of rhCNTF. These findings demonstrate that, in contrast to its well-characterized trophic effects on cells of the nervous system, rhCNTF causes atrophy of skeletal muscle by mechanisms involving both anorexia and cachexia based on the results of pair-feeding experiments.
Collapse
Affiliation(s)
- D Martin
- Department of Pharmacology, Synergen, Boulder 80301, USA
| | | | | | | | | | | | | |
Collapse
|
16
|
Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, Gleason TM, Russell D. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994; 135:1913-20. [PMID: 7525258 DOI: 10.1210/endo.135.5.7525258] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
We have examined the effects of exogenously administered recombinant human insulin-like growth factor-binding protein-1 (rhIGFBP-1) alone and in combination with recombinant human insulin-like growth factor-I (rhIGF-I) or human GH on weight gain and tibial epiphysis enlargement in hypophysectomized rats. rhIGF-I, given twice daily by sc injection, increased both growth parameters in a dose-dependent manner. Coadministration of increasing amounts of rhIGFBP-1 with a constant amount of rhIGF-I (80 micrograms/injection, given twice daily) resulted in a dose-dependent inhibition of the growth-promoting effects of rhIGF-I. A rhIGFBP-1 dose of 9.8 micrograms/injection (an IGFBP-1/IGF-I molar ratio of 0.04:1) caused no significant effect on rhIGF-I-stimulated growth parameters, whereas a rhIGFBP-1 dose of 1200 micrograms/injection (IGFBP-1/IGF-I molar ratio of 5:1) resulted in 78% or greater inhibition of rhIGF-I-stimulated growth (P < 0.05). rhIGFBP-1 doses of 48 and 240 micrograms/injection (IGFBP-1/IGF-I molar ratios of 0.2:1 and 1:1, respectively) had intermediate inhibitory effects. None of the rhIGFBP-1 doses potentiated the growth-promoting effects of rhIGF-I. Rats treated with rhIGFBP-1 alone (twice daily injections of 9.8, 48, 240, or 1200 micrograms) showed no significant differences in growth parameters compared to rats treated with vehicle. Coadministration of rhIGFBP-1 (1200 micrograms/injection, given twice daily) with GH (15 mU/injection, given twice daily) inhibited weight gain and tibial epiphysis enlargement stimulated by GH by at least 50% in each of two experiments (P < 0.05). These studies demonstrate that nonphosphorylated rhIGFBP-1 can inhibit the growth-promoting effects of rhIGF-I and GH in vivo. The results suggest that in addition to its proposed role in glucose homeostasis, IGFBP-1 may play a role in inhibiting somatic growth and other physiological functions stimulated by IGF-I and GH.
Collapse
Affiliation(s)
- G N Cox
- Synergen, Inc., Boulder, Colorado 80301
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Merkel E. Tips on how and when to use written communication. Healthc Financ Manage 1990; 44:66. [PMID: 10145223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
|
18
|
Merkel E. Mengenberechnungen in der Chemie. VonW. Kullbach. Verlag Chemie, Weinheim - Deerfield Beach - Basel 1980. 1. Aufl., XIII, 474 S., 16 Abb., 16 Tab., brosch., DM 48,-. CHEM-ING-TECH 1982. [DOI: 10.1002/cite.330540222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
19
|
Merkel E. Farbenfabriken Bayer, Werk Ürdingen. Angew Chem Int Ed Engl 1950. [DOI: 10.1002/ange.19500621711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
20
|
|
21
|
Marx, Strassmann G, Meixner, Buhtz, Reuter K, Wohlgemuth, Merkel E. Spurennachweis. Leichenerscheinungen. Int J Legal Med 1928. [DOI: 10.1007/bf01763577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|